Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News

20:45 EST 15th January 2019 | BioPortfolio

Showing News Articles 1–25 of 440,000+

Tuesday 15th January 2019

Health Mindsets Report from Syneos Health: How to Diversify Marketing Efforts According to Consumer Healthcare Attitudes

That consumers are engaged with their own healthcare more now than ever before might make it all too easy to overlook how deeply their modes of engagement differ from one another. It sounds logical to assume that general engagement with information would reliably predict engagement with healthcare information, but a Syneos HealthTM survey uncovered exactly […] The post Health Mindsets Report...

Newly public documents reveal how aggressively Purdue pursued tight relationships with Tufts University and Massachusetts General Hospital to expand OxyContin prescribing. https://buff.ly/2VWOKXd 

Newly public documents reveal how aggressively Purdue pursued tight relationships with Tufts University and Massachusetts General Hospital to expand OxyContin prescribing. https://buff.ly/2VWOKXd 

. @SBPdiscovery researchers identify epigenetic marker and 2 genes that caused heart failure in children and grandchildren of fruit flies with high-fat-diet-induced heart dysfunction: http://ow.ly/jP6i30nk01j 

. @SBPdiscovery researchers identify epigenetic marker and 2 genes that caused heart failure in children and grandchildren of fruit flies with high-fat-diet-induced heart dysfunction: http://ow.ly/jP6i30nk01j 

LIBERTY Dental Scores High 5 Award from First 5 Sacramento

LIBERTY Dental Plan is honored to announce that on January 8, 2019, we received the “High 5 Award” from the Sacramento, California First 5 Commission at the “Raise Up Sacramento” ceremony held at the Golden One Center. The award was given in recognition of the work LIBERTY is doing in Sacramento County, along with Health Net and Access Dental, for ...

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt

The UK’s new five-year pricing agreement

Pharma has agreed to capped growth again – in exchange for uptake promises

As the March for Life approaches, anti-abortion leaders are rebranding as ‘pro-science.’ Scientists say otherwise. https://buff.ly/2DbRYyN 

As the March for Life approaches, anti-abortion leaders are rebranding as ‘pro-science.’ Scientists say otherwise. https://buff.ly/2DbRYyN 

Researchers at @karolinskainst , @UniOslo say study may aid development of #vaccines and #immunotherapy used in #Cancer: http://ow.ly/1x0M30njZM7 

Researchers at @karolinskainst , @UniOslo say study may aid development of #vaccines and #immunotherapy used in #Cancer: http://ow.ly/1x0M30njZM7 

It's never too late to quit smoking before lung surgery

(Reuters Health) - Smokers who'll be having surgery for lung cancer should quit smoking before the operation, and the sooner the better, a new study shows.

Ventas Announces Treatment of 2018 Distributions

Ventas, Inc. (NYSE: VTR) announced today the tax treatment of its 2018 distributions. The Company’s dividends for 2018 totaled $3.1625 per share, taking into account its first through fourth quarter 2018 dividends whose ex-dividend dates all occurred in 2018. For income tax purposes, total taxable dividend income for 2018 was $3....

India ICP Procedures Outlook to 2025 [Report Updated: 01112018] Prices from USD $2995

India ICP Procedures Outlook to 2025SummaryGlobalData's new report, India ICP Procedures Outlook to 2025, provides key procedures data on the India ICP Procedures. The report provides procedure volumes within market segment ICP Procedures.The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes....

A new law may give rise to more treatments for children with cancer https://www.wsj.com/articles/for-children-with-cancer-hope-for-new-treatments-11547561004 … via @WSJ

A new law may give rise to more treatments for children with cancer https://www.wsj.com/articles/for-children-with-cancer-hope-for-new-treatments-11547561004 … via @WSJ

STAT Plus: AmerisourceBergen will eliminate 15 percent of workers at a troubled compounding unit. https://buff.ly/2FuCAjx 

STAT Plus: AmerisourceBergen will eliminate 15 percent of workers at a troubled compounding unit. https://buff.ly/2FuCAjx 

Fever Alters Immune Cells so They can Better Reach Infections

NewsFever is known to help power up our immune cells, and scientists in Shanghai have new evidence explaining how. Contributed Author: 

"You’re changing your brain with just one or two joints. Most people would likely assume that one or two joints would have no impact on the brain.” http://ow.ly/q39o30nk05J 

"You’re changing your brain with just one or two joints. Most people would likely assume that one or two joints would have no impact on the brain.” http://ow.ly/q39o30nk05J 

STAT Plus: AmerisourceBergen will eliminate 15 percent of workers at a troubled compounding unit

AmerisourceBergen (ABC), one of the nation’s largest pharmaceutical wholesalers, is eliminating 225 jobs — roughly 15 percent of the entire workforce — at Pharmedium Services, its troubled compounding unit that…

Mary Ann Liebert, Inc. Provides Lunch to Local Air Traffic Controllers in Wake of Government #Shutdown https://home.liebertpub.com/news/mary-ann-liebert-inc-provides-lunch-to-local-air-traffic-controllers/3493 … @FAANews @lohud @News12WC @AppleNews

Mary Ann Liebert, Inc. Provides Lunch to Local Air Traffic Controllers in Wake of Government #Shutdown https://home.liebertpub.com/news/mary-ann-liebert-inc-provides-lunch-to-local-air-traffic-controllers/3493 … @FAANews @lohud @News12WC @AppleNews

Apple-Aktie: Das sind positive Signale!

Apple konnte auch am Dienstag wieder zulegen. Es ging um fast 2 % nach oben. In den USA verteidigte der Wert eine bedeutende Untergrenze und kann sich gerade charttechnisch betrachtet wieder deutli...

NHI Announces $50.3M Purchase and Leaseback of MA Senior Living Campus

National Health Investors (NYSE: NHI) announced today it has agreed to purchase and leaseback a senior living campus in Massachusetts for a total initial investment of $50.3 million. The lease has a 10-year maturity with three 5-year renewal options and an initial annual lease rate of 7.5% plus annual fixed escalators. NHI has committed up to $1.9 million ...

Bankbilanzen lassen US-Börsen stocken - Konjunkturhilfen stützen: Enttäuschende Zahlen von JP Morgan ...

Enttäuschende Zahlen von JP Morgan und Wells Fargo haben an der Wall Street für Ernüchterung gesorgt. Durch einen chinesischen Konjunkturaufschub blieb der Dow Jones im Plus.Gestützt von der Ankünd...

STAT Plus: “There is a paradox here,” said Dr. Thomas Hwang. https://buff.ly/2DbWUnv 

STAT Plus: “There is a paradox here,” said Dr. Thomas Hwang. https://buff.ly/2DbWUnv 

Taro Announces Completion of $250 Million Share Repurchase Program

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it has completed its $250 million share repurchase program. The company bought back 2,493,378 of its ordinary shares in open market transactions at an average price of $100.28 per share. The repurchase program was announced by the company on November 23, 2016, and was completed on Januar...

Lianluo Smart Expands Its Sleep Diagnostic Offering Into More Than Forty Major Public Hospitals in China

BEIJING, Jan. 15, 2019 /PRNewswire/ -- Lianluo Smart Limited ("Lianluo Smart" or the "Company") (Nasdaq: LLIT), a China based professional smart service and products provider today announced its wearable sleep diagnostic product and cloud-based service from the Company's wholly owned subsidiary, Lianluo Connection Medical Wearable Device Technology...

Kaiser Health News Report: Clinics Treating Immigrants Find Themselves in Limbo Around Notification

Mark Hagland, Editor-in-ChiefThe clinicians and leaders of U.S. patient care organizations continue to find themselves in a policy limbo around the information they share with federal and state authorities around their care for undocumented immigrants

Biomunex Pharmaceuticals signs first partnership agreement to develop bi- and multi-specific antibodies using its platform with @sanofi: http://ow.ly/Rl3130nk0eH 

Biomunex Pharmaceuticals signs first partnership agreement to develop bi- and multi-specific antibodies using its platform with @sanofi: http://ow.ly/Rl3130nk0eH 


Advertisement
Quick Search
Advertisement
Advertisement

 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device tracking service collates press releases, news articles and blogs from over 500 sources.  Continuous news is published on the BioPortfolio site, categorised into core topics and posted to our social media accounts - currently 127,000 followers (January 2019):